Evolent Health, Inc. — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Evolent Health, Inc. (EVH)
CIK: 0001628908
Period of Report: 2021-02-01

Reporting Person: KECK KIM (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Class A Common Stock	A	2875	—	Acquired	2875	Direct

Footnotes

F1: Represents restricted stock units granted to Ms. Keck pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

F2: Securities vest on the earlier of February 1, 2022 and the date of the company's 2021 annual meeting, subject to the reporting person's continued service on the vesting date.